Randomised trial of letrozole plus usual care versus usual care without letrozole to prevent new breast cancer events in postmenopausal women who have completed a minimum of 4 years of adjuvant endocrine therapy for early, hormone responsive breast cancer more than 1 year previous, and who are disease-free at trial entry (ANZ 0501 LATER)
收藏DataCite Commons2023-06-08 更新2024-07-13 收录
下载链接：
https://doi.breastcancertrials.org.au/6
下载链接
链接失效反馈官方服务：
资源简介：
HeSANDA 1.0.0
HeSANDA 1.0.0 数据集
提供机构：
Breast Cancer Trials (BCT)
创建时间：
2023-05-31
